{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T18:46:51Z","timestamp":1792522011367,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T00:00:00Z","timestamp":1603238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Autoimmunity can occur when a checkpoint of self-tolerance fails. The study of familial autoimmune diseases can reveal pathophysiological mechanisms involved in more common autoimmune diseases. Here, by whole-exome\/genome sequencing we identify heterozygous, autosomal-dominant, germline loss-of-function mutations in the <jats:italic>SOCS1<\/jats:italic> gene in ten patients from five unrelated families with early onset autoimmune manifestations. The intracellular protein SOCS1 is known to downregulate cytokine signaling by inhibiting the JAK-STAT pathway. Accordingly, patient-derived lymphocytes exhibit increased STAT activation in vitro in response to interferon-\u03b3, IL-2 and IL-4 that is reverted by the JAK1\/JAK2 inhibitor ruxolitinib. This effect is associated with a series of in vitro and in vivo immune abnormalities consistent with lymphocyte hyperactivity. Hence, <jats:italic>SOCS1<\/jats:italic> haploinsufficiency causes a dominantly inherited predisposition to early onset autoimmune diseases related to cytokine hypersensitivity of immune cells.<\/jats:p>","DOI":"10.1038\/s41467-020-18925-4","type":"journal-article","created":{"date-parts":[[2020,10,21]],"date-time":"2020-10-21T10:04:15Z","timestamp":1603274655000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":157,"title":["Early-onset autoimmunity associated with SOCS1 haploinsufficiency"],"prefix":"10.1038","volume":"11","author":[{"given":"J\u00e9r\u00f4me","family":"Hadjadj","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2689-9072","authenticated-orcid":false,"given":"Carla Noemi","family":"Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maud","family":"Tusseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Claude","family":"Stolzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabienne","family":"Mazerolles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Aladjidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Houman","family":"Ashrafian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioana","family":"Cutcutache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"Ebetsberger-Dachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8125-797X","authenticated-orcid":false,"given":"Katherine S.","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Durieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fabien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Fusaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9594-1377","authenticated-orcid":false,"given":"Maximilian","family":"Heeg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohan","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Bras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-5536","authenticated-orcid":false,"given":"Julian C.","family":"Knight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Lega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7691-9492","authenticated-orcid":false,"given":"Gaetan","family":"Lesca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Laure","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Moreews","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baptiste","family":"Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Nosbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Page","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9284-4531","authenticated-orcid":false,"given":"C\u00e9cile","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Ronan Leahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Rouvet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ethel","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damien","family":"Sanlaville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Francois","family":"Viallard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5085-443X","authenticated-orcid":false,"given":"Sebastien","family":"Viel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3905-8993","authenticated-orcid":false,"given":"Marine","family":"Villard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Callebaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Capucine","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Walzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain","family":"Fischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Neven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4902-5332","authenticated-orcid":false,"given":"Alexandre","family":"Belot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7858-7866","authenticated-orcid":false,"given":"Fr\u00e9d\u00e9ric","family":"Rieux-Laucat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,10,21]]},"reference":[{"key":"18925_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.cell.2007.06.033","volume":"130","author":"CC Goodnow","year":"2007","unstructured":"Goodnow, C. C. Multistep pathogenesis of autoimmune disease. Cell 130, 25\u201335 (2007).","journal-title":"Cell"},{"key":"18925_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jaci.2015.11.004","volume":"137","author":"B Grimbacher","year":"2016","unstructured":"Grimbacher, B., Warnatz, K., Yong, P. F. K., Korganow, A.-S. & Peter, H.-H. The crossroads of autoimmunity and immunodeficiency: Lessons from polygenic traits and monogenic defects. J. Allergy Clin. Immunol. 137, 3\u201317 (2016).","journal-title":"J. Allergy Clin. Immunol."},{"key":"18925_CR3","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1038\/ni.3691","volume":"18","author":"AV Villarino","year":"2017","unstructured":"Villarino, A. V., Kanno, Y. & O\u2019Shea, J. J. Mechanisms and consequences of Jak-STAT signaling in the immune system. Nat. Immunol. 18, 374\u2013384 (2017).","journal-title":"Nat. Immunol."},{"key":"18925_CR4","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1038\/nri2093","volume":"7","author":"A Yoshimura","year":"2007","unstructured":"Yoshimura, A., Naka, T. & Kubo, M. SOCS proteins, cytokine signalling and immune regulation. Nat. Rev. Immunol. 7, 454\u2013465 (2007).","journal-title":"Nat. Rev. Immunol."},{"key":"18925_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-04013-1","volume":"9","author":"NPD Liau","year":"2018","unstructured":"Liau, N. P. D. et al. The molecular basis of JAK\/STAT inhibition by SOCS1. Nat. Commun. 9, 1558 (2018).","journal-title":"Nat. Commun."},{"key":"18925_CR6","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/nmeth.3739","volume":"13","author":"Y Itan","year":"2016","unstructured":"Itan, Y. et al. The mutation significance cutoff: gene-level thresholds for variant predictions. Nat. Methods 13, 109\u2013110 (2016).","journal-title":"Nat. Methods"},{"key":"18925_CR7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s13045-017-0438-7","volume":"10","author":"D Juskevicius","year":"2017","unstructured":"Juskevicius, D. et al. Mutations of CREBBP and SOCS1 are independent prognostic factors in diffuse large B cell lymphoma: mutational analysis of the SAKK 38\/07 prospective clinical trial cohort. J. Hematol. Oncol. 10, 70 (2017).","journal-title":"J. Hematol. Oncol."},{"key":"18925_CR8","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1002\/gcc.22328","volume":"55","author":"S Mareschal","year":"2016","unstructured":"Mareschal, S. et al. Whole exome sequencing of relapsed\/refractory patients expands the repertoire of somatic mutations in diffuse large B-cell lymphoma. Genes Chromosomes Cancer 55, 251\u2013267 (2016).","journal-title":"Genes Chromosomes Cancer"},{"key":"18925_CR9","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.1084\/jem.20110428","volume":"208","author":"R Takahashi","year":"2011","unstructured":"Takahashi, R. et al. SOCS1 is essential for regulatory T cell functions by preventing loss of Foxp3 expression as well as IFN-{gamma} and IL-17A production. J. Exp. Med. 208, 2055\u20132067 (2011).","journal-title":"J. Exp. Med."},{"key":"18925_CR10","doi-asserted-by":"publisher","first-page":"149","DOI":"10.4049\/jimmunol.1600441","volume":"199","author":"R Takahashi","year":"2017","unstructured":"Takahashi, R., Nakatsukasa, H., Shiozawa, S. & Yoshimura, A. SOCS1 Is a key molecule that prevents regulatory T cell plasticity under inflammatory conditions. J. Immunol. 199, 149\u2013158 (2017).","journal-title":"J. Immunol."},{"key":"18925_CR11","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1093\/intimm\/dxf094","volume":"14","author":"M Fujimoto","year":"2002","unstructured":"Fujimoto, M. et al. A regulatory role for suppressor of cytokine signaling-1 in T(h) polarization in vivo. Int. Immunol. 14, 1343\u20131350 (2002).","journal-title":"Int. Immunol."},{"key":"18925_CR12","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1016\/S0092-8674(00)80047-1","volume":"98","author":"WS Alexander","year":"1999","unstructured":"Alexander, W. S. et al. SOCS1 is a critical inhibitor of interferon gamma signaling and prevents the potentially fatal neonatal actions of this cytokine. Cell 98, 597\u2013608 (1999).","journal-title":"Cell"},{"key":"18925_CR13","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/S1074-7613(03)00240-1","volume":"19","author":"T Hanada","year":"2003","unstructured":"Hanada, T. et al. Suppressor of cytokine signaling-1 is essential for suppressing dendritic cell activation and systemic autoimmunity. Immunity 19, 437\u2013450 (2003).","journal-title":"Immunity"},{"key":"18925_CR14","doi-asserted-by":"publisher","first-page":"1292","DOI":"10.3389\/fimmu.2017.01292","volume":"8","author":"H Wang","year":"2017","unstructured":"Wang, H., Wang, J. & Xia, Y. Defective suppressor of cytokine signaling 1 signaling contributes to the pathogenesis of systemic lupus erythematosus. Front Immunol. 8, 1292 (2017).","journal-title":"Front Immunol."},{"key":"18925_CR15","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1093\/intimm\/dxh030","volume":"16","author":"M Fujimoto","year":"2004","unstructured":"Fujimoto, M. et al. Inadequate induction of suppressor of cytokine signaling-1 causes systemic autoimmune diseases. Int. Immunol. 16, 303\u2013314 (2004).","journal-title":"Int. Immunol."},{"key":"18925_CR16","doi-asserted-by":"publisher","unstructured":"Thaventhiran, J. E. D. et al. Whole-genome sequencing of a sporadic primary immunodeficiency cohort. Nature 1\u20136. https:\/\/doi.org\/10.1038\/s41586-020-2265-1 (2020).","DOI":"10.1038\/s41586-020-2265-1"},{"key":"18925_CR17","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1038\/ng.3040","volume":"46","author":"SE Flanagan","year":"2014","unstructured":"Flanagan, S. E. et al. Activating germline mutations in STAT3 cause early-onset multi-organ autoimmune disease. Nat. Genet. 46, 812\u2013814 (2014).","journal-title":"Nat. Genet."},{"key":"18925_CR18","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1084\/jem.20110958","volume":"208","author":"L Liu","year":"2011","unstructured":"Liu, L. et al. Gain-of-function human STAT1 mutations impair IL-17 immunity and underlie chronic mucocutaneous candidiasis. J. Exp. Med. 208, 1635\u20131648 (2011).","journal-title":"J. Exp. Med."},{"key":"18925_CR19","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1056\/NEJMoa1100102","volume":"365","author":"FL van de Veerdonk","year":"2011","unstructured":"van de Veerdonk, F. L. et al. STAT1 mutations in autosomal dominant chronic mucocutaneous candidiasis. N. Engl. J. Med. 365, 54\u201361 (2011).","journal-title":"N. Engl. J. Med."},{"key":"18925_CR20","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1182\/blood-2014-09-602763","volume":"125","author":"JD Milner","year":"2015","unstructured":"Milner, J. D. et al. Early-onset lymphoproliferation and autoimmunity caused by germline STAT3 gain-of-function mutations. Blood 125, 591\u2013599 (2015).","journal-title":"Blood"},{"key":"18925_CR21","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1182\/blood-2014-04-570101","volume":"125","author":"EM Haapaniemi","year":"2015","unstructured":"Haapaniemi, E. M. et al. Autoimmunity, hypogammaglobulinemia, lymphoproliferation, and mycobacterial disease in patients with activating mutations in STAT3. Blood 125, 639\u2013648 (2015).","journal-title":"Blood"},{"key":"18925_CR22","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1016\/S0092-8674(00)80048-3","volume":"98","author":"JC Marine","year":"1999","unstructured":"Marine, J. C. et al. SOCS1 deficiency causes a lymphocyte-dependent perinatal lethality. Cell 98, 609\u2013616 (1999).","journal-title":"Cell"},{"key":"18925_CR23","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1182\/blood-2004-08-3049","volume":"106","author":"MMW Chong","year":"2005","unstructured":"Chong, M. M. W., Metcalf, D., Jamieson, E., Alexander, W. S. & Kay, T. W. H. Suppressor of cytokine signaling-1 in T cells and macrophages is critical for preventing lethal inflammation. Blood 106, 1668\u20131675 (2005).","journal-title":"Blood"},{"key":"18925_CR24","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1126\/science.1255904","volume":"345","author":"HS Kuehn","year":"2014","unstructured":"Kuehn, H. S. et al. Immune dysregulation in human subjects with heterozygous germline mutations in CTLA4. Science 345, 1623\u20131627 (2014).","journal-title":"Science"},{"key":"18925_CR25","doi-asserted-by":"publisher","unstructured":"Schwab, C. et al. Phenotype, penetrance, and treatment of 133 cytotoxic T-lymphocyte antigen 4-insufficient subjects. J. Allergy Clin. Immunol. https:\/\/doi.org\/10.1016\/j.jaci.2018.02.055 (2018).","DOI":"10.1016\/j.jaci.2018.02.055"},{"key":"18925_CR26","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1056\/NEJMoa1512234","volume":"374","author":"HS Kuehn","year":"2016","unstructured":"Kuehn, H. S. et al. Loss of B cells in patients with heterozygous mutations in IKAROS. N. Engl. J. Med. 374, 1032\u20131043 (2016).","journal-title":"N. Engl. J. Med."},{"key":"18925_CR27","doi-asserted-by":"publisher","first-page":"4798","DOI":"10.1182\/blood-2011-04-347641","volume":"118","author":"B Neven","year":"2011","unstructured":"Neven, B. et al. A survey of 90 patients with autoimmune lymphoproliferative syndrome related to TNFRSF6 mutation. Blood 118, 4798\u20134807 (2011).","journal-title":"Blood"},{"key":"18925_CR28","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/JCI43752","volume":"121","author":"A Magerus-Chatinet","year":"2011","unstructured":"Magerus-Chatinet, A. et al. Onset of autoimmune lymphoproliferative syndrome (ALPS) in humans as a consequence of genetic defect accumulation. J. Clin. Invest. 121, 106\u2013112 (2011).","journal-title":"J. Clin. Invest."},{"key":"18925_CR29","first-page":"2575","volume":"94","author":"F Rieux-Laucat","year":"1999","unstructured":"Rieux-Laucat, F. et al. Lymphoproliferative syndrome with autoimmunity: a possible genetic basis for dominant expression of the clinical manifestations. Blood 94, 2575\u20132582 (1999).","journal-title":"Blood"},{"key":"18925_CR30","doi-asserted-by":"publisher","first-page":"1028","DOI":"10.1016\/j.jaci.2017.05.024","volume":"141","author":"PC Mayor","year":"2018","unstructured":"Mayor, P. C. et al. Cancer in primary immunodeficiency diseases: cancer incidence in the United States immune deficiency network registry. J. Allergy Clin. Immunol. 141, 1028\u20131035 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"18925_CR31","doi-asserted-by":"publisher","first-page":"3387","DOI":"10.1182\/blood-2007-03-082511","volume":"110","author":"A Mottok","year":"2007","unstructured":"Mottok, A., Renn\u00e9, C., Willenbrock, K., Hansmann, M.-L. & Br\u00e4uninger, A. Somatic hypermutation of SOCS1 in lymphocyte-predominant Hodgkin lymphoma is accompanied by high JAK2 expression and activation of STAT6. Blood 110, 3387\u20133390 (2007).","journal-title":"Blood"},{"key":"18925_CR32","doi-asserted-by":"publisher","first-page":"4503","DOI":"10.1182\/blood-2009-06-225839","volume":"114","author":"A Mottok","year":"2009","unstructured":"Mottok, A. et al. Inactivating SOCS1 mutations are caused by aberrant somatic hypermutation and restricted to a subset of B-cell lymphoma entities. Blood 114, 4503\u20134506 (2009).","journal-title":"Blood"},{"key":"18925_CR33","doi-asserted-by":"publisher","first-page":"2535","DOI":"10.1182\/blood-2004-09-3701","volume":"105","author":"I Melzner","year":"2005","unstructured":"Melzner, I. et al. Biallelic mutation of SOCS-1 impairs JAK2 degradation and sustains phospho-JAK2 action in the MedB-1 mediastinal lymphoma line. Blood 105, 2535\u20132542 (2005).","journal-title":"Blood"},{"key":"18925_CR34","doi-asserted-by":"publisher","first-page":"1665","DOI":"10.1016\/j.jaci.2018.07.020","volume":"142","author":"LR Forbes","year":"2018","unstructured":"Forbes, L. R. et al. Jakinibs for the treatment of immune dysregulation in patients with gain-of-function signal transducer and activator of transcription 1 (STAT1) or STAT3 mutations. J. Allergy Clin. Immunol. 142, 1665\u20131669 (2018).","journal-title":"J. Allergy Clin. Immunol."},{"key":"18925_CR35","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.tips.2019.03.001","volume":"40","author":"GA Durham","year":"2019","unstructured":"Durham, G. A., Williams, J. J. L., Nasim, M. T. & Palmer, T. M. Targeting SOCS proteins to control JAK-STAT signalling in disease. Trends Pharmacol. Sci. 40, 298\u2013308 (2019).","journal-title":"Trends Pharmacol. Sci."},{"key":"18925_CR36","doi-asserted-by":"publisher","first-page":"324","DOI":"10.3389\/fphar.2019.00324","volume":"10","author":"J Sharma","year":"2019","unstructured":"Sharma, J. & Larkin, J. Therapeutic implication of SOCS1 modulation in the treatment of autoimmunity and cancer. Front Pharm. 10, 324 (2019).","journal-title":"Front Pharm."},{"key":"18925_CR37","doi-asserted-by":"publisher","first-page":"4307","DOI":"10.1093\/bioinformatics\/bty536","volume":"34","author":"P Zhang","year":"2018","unstructured":"Zhang, P. et al. PopViz: a webserver for visualizing minor allele frequencies and damage prediction scores of human genetic variations. Bioinformatics 34, 4307\u20134309 (2018).","journal-title":"Bioinformatics"},{"key":"18925_CR38","doi-asserted-by":"publisher","first-page":"5.6.1","DOI":"10.1002\/cpbi.3","volume":"54","author":"B Webb","year":"2016","unstructured":"Webb, B. & Sali, A. Comparative protein structure modeling using MODELLER. Curr. Protoc. Bioinform. 54, 5.6.1\u20135.6.37 (2016).","journal-title":"Curr. Protoc. Bioinform."},{"key":"18925_CR39","doi-asserted-by":"publisher","first-page":"1605","DOI":"10.1002\/jcc.20084","volume":"25","author":"EF Pettersen","year":"2004","unstructured":"Pettersen, E. F. et al. UCSF Chimera-a visualization system for exploratory research and analysis. J. Comput. Chem. 25, 1605\u20131612 (2004).","journal-title":"J. Comput. Chem."},{"key":"18925_CR40","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1038\/nm.4019","volume":"22","author":"B Zaragoza","year":"2016","unstructured":"Zaragoza, B. et al. Suppressive activity of human regulatory T cells is maintained in the presence of TNF. Nat. Med. 22, 16\u201317 (2016).","journal-title":"Nat. Med."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18925-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18925-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T01:31:05Z","timestamp":1670290265000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-020-18925-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10,21]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2020,12]]}},"alternative-id":["18925"],"URL":"https:\/\/doi.org\/10.1038\/s41467-020-18925-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,10,21]]},"assertion":[{"value":"1 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"5341"}}